a public good project by the
Synthesis
Company
of California

© 2026

Cuijian Zhang | doi.page

0 works0 citations0 h-index

Cuijian Zhang

Peking University(CN)Beijing Biocytogen (China)(CN)Peking University First Hospital(CN)

Publications by Year

Research Areas

Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Renal and related cancers, Ferroptosis and cancer prognosis, Urinary and Genital Oncology Studies

Most-Cited Works

→ Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer(2018)84 cited
→ Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis(2018)77 cited
→ Robot-assisted Partial Nephrectomy with the Newly Developed KangDuo Surgical Robot Versus the da Vinci Si Surgical System: A Double-center Prospective Randomized Controlled Noninferiority Trial(2022)52 cited
→ MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T(2022)42 cited
→ The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy(2015)42 cited
→ The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy(2015)39 cited

→ Laparoscopic total pelvic exenteration for pelvic malignancies: the technique and short-time outcome of 11 cases(2015)39 cited

→ Prognostic and Predictive Value of Epigenetic Biomarkers and Clinical Factors in Upper Tract Urothelial Carcinoma(2015)31 cited

→ A Modified Suture Technique for Transperitoneal Laparoscopic Dismembered Pyeloplasty of Pelviureteric Junction Obstruction(2014)31 cited

→ Potent antitumour of the mTORC1/2 dual inhibitor AZD2014 in docetaxel‐sensitive and docetaxel‐resistant castration‐resistant prostate cancer cells(2021)28 cited